Analysis of human non-small-cell lung carcinoma (NSCLC) tumours graded from stage 1 to 3A revealed that p105 stromal and epithelial tumour cell expression was a positive prognostic indicator of disease-specific survival [40]. This evidence concerns the gene NFKB1 and non-small cell lung carcinoma.